vs

Side-by-side financial comparison of MetLife (MET) and Sotera Health Co (SHC). Click either name above to swap in a different company.

MetLife is the larger business by last-quarter revenue ($600.0M vs $303.4M, roughly 2.0× Sotera Health Co). MetLife runs the higher net margin — 134.8% vs 11.5%, a 123.3% gap on every dollar of revenue. On growth, MetLife posted the faster year-over-year revenue change (7.9% vs 4.6%). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs 2.0%).

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

MET vs SHC — Head-to-Head

Bigger by revenue
MET
MET
2.0× larger
MET
$600.0M
$303.4M
SHC
Growing faster (revenue YoY)
MET
MET
+3.4% gap
MET
7.9%
4.6%
SHC
Higher net margin
MET
MET
123.3% more per $
MET
134.8%
11.5%
SHC
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
2.0%
MET

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MET
MET
SHC
SHC
Revenue
$600.0M
$303.4M
Net Profit
$809.0M
$34.8M
Gross Margin
54.7%
Operating Margin
23.2%
Net Margin
134.8%
11.5%
Revenue YoY
7.9%
4.6%
Net Profit YoY
-36.3%
182.8%
EPS (diluted)
$1.18
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MET
MET
SHC
SHC
Q4 25
$600.0M
$303.4M
Q3 25
$621.0M
$311.3M
Q2 25
$604.0M
$294.3M
Q1 25
$611.0M
$254.5M
Q4 24
$556.0M
$290.2M
Q3 24
$554.0M
$285.5M
Q2 24
$558.0M
$276.6M
Q1 24
$577.0M
$248.2M
Net Profit
MET
MET
SHC
SHC
Q4 25
$809.0M
$34.8M
Q3 25
$896.0M
$48.4M
Q2 25
$729.0M
$8.0M
Q1 25
$945.0M
$-13.3M
Q4 24
$1.3B
$12.3M
Q3 24
$1.3B
$17.0M
Q2 24
$946.0M
$8.8M
Q1 24
$867.0M
$6.3M
Gross Margin
MET
MET
SHC
SHC
Q4 25
54.7%
Q3 25
57.0%
Q2 25
56.6%
Q1 25
53.2%
Q4 24
56.6%
Q3 24
55.4%
Q2 24
55.2%
Q1 24
51.2%
Operating Margin
MET
MET
SHC
SHC
Q4 25
23.2%
Q3 25
23.4%
Q2 25
6.4%
Q1 25
-5.8%
Q4 24
30.0%
Q3 24
28.2%
Q2 24
27.8%
Q1 24
21.4%
Net Margin
MET
MET
SHC
SHC
Q4 25
134.8%
11.5%
Q3 25
144.3%
15.5%
Q2 25
120.7%
2.7%
Q1 25
154.7%
-5.2%
Q4 24
228.6%
4.2%
Q3 24
242.2%
6.0%
Q2 24
169.5%
3.2%
Q1 24
150.3%
2.5%
EPS (diluted)
MET
MET
SHC
SHC
Q4 25
$1.18
$0.12
Q3 25
$1.22
$0.17
Q2 25
$1.03
$0.03
Q1 25
$1.28
$-0.05
Q4 24
$1.75
$0.05
Q3 24
$1.81
$0.06
Q2 24
$1.28
$0.03
Q1 24
$1.10
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MET
MET
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$25.6B
$344.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$28.4B
$606.0M
Total Assets
$745.2B
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MET
MET
SHC
SHC
Q4 25
$25.6B
$344.6M
Q3 25
$26.2B
$299.2M
Q2 25
$27.5B
$332.4M
Q1 25
$26.9B
$304.4M
Q4 24
$25.2B
$277.2M
Q3 24
$26.4B
$306.7M
Q2 24
$24.6B
$246.1M
Q1 24
$24.7B
$261.1M
Total Debt
MET
MET
SHC
SHC
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.2B
Stockholders' Equity
MET
MET
SHC
SHC
Q4 25
$28.4B
$606.0M
Q3 25
$28.9B
$550.5M
Q2 25
$27.7B
$511.3M
Q1 25
$27.5B
$414.1M
Q4 24
$27.4B
$404.9M
Q3 24
$30.9B
$470.2M
Q2 24
$27.3B
$422.8M
Q1 24
$28.5B
$429.4M
Total Assets
MET
MET
SHC
SHC
Q4 25
$745.2B
$3.3B
Q3 25
$719.7B
$3.2B
Q2 25
$702.5B
$3.2B
Q1 25
$688.3B
$3.1B
Q4 24
$677.5B
$3.1B
Q3 24
$705.0B
$3.1B
Q2 24
$675.7B
$3.1B
Q1 24
$677.6B
$3.1B
Debt / Equity
MET
MET
SHC
SHC
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MET
MET
SHC
SHC
Operating Cash FlowLast quarter
$7.1B
$103.1M
Free Cash FlowOCF − Capex
$52.4M
FCF MarginFCF / Revenue
17.3%
Capex IntensityCapex / Revenue
16.7%
Cash ConversionOCF / Net Profit
8.75×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MET
MET
SHC
SHC
Q4 25
$7.1B
$103.1M
Q3 25
$3.6B
$71.2M
Q2 25
$2.2B
$57.4M
Q1 25
$4.3B
$55.5M
Q4 24
$4.6B
$55.7M
Q3 24
$4.2B
$97.5M
Q2 24
$3.5B
$61.3M
Q1 24
$2.3B
$9.7M
Free Cash Flow
MET
MET
SHC
SHC
Q4 25
$52.4M
Q3 25
$35.0M
Q2 25
$26.2M
Q1 25
$35.6M
Q4 24
$-10.2M
Q3 24
$61.1M
Q2 24
$19.4M
Q1 24
$-25.2M
FCF Margin
MET
MET
SHC
SHC
Q4 25
17.3%
Q3 25
11.2%
Q2 25
8.9%
Q1 25
14.0%
Q4 24
-3.5%
Q3 24
21.4%
Q2 24
7.0%
Q1 24
-10.2%
Capex Intensity
MET
MET
SHC
SHC
Q4 25
16.7%
Q3 25
11.6%
Q2 25
10.6%
Q1 25
7.8%
Q4 24
22.7%
Q3 24
12.7%
Q2 24
15.2%
Q1 24
14.1%
Cash Conversion
MET
MET
SHC
SHC
Q4 25
8.75×
2.96×
Q3 25
3.98×
1.47×
Q2 25
3.00×
7.21×
Q1 25
4.51×
Q4 24
3.63×
4.52×
Q3 24
3.11×
5.73×
Q2 24
3.69×
7.00×
Q1 24
2.69×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MET
MET

Other$165.0M28%
Prepaidlegalplansandadministrativeonlycontracts$158.0M26%
Vision Fee For Service Arrangements$140.0M23%
Administrative Service$76.0M13%
Distribution Service$36.0M6%
Feebasedinvestmentmanagementservices$25.0M4%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons